Cyprodenate
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | N06BX04 |
Identifiers | |
| |
CAS Number | 15585-86-1 Y |
PubChem (CID) | 71875 |
ChemSpider | 64892 Y |
UNII | I44VIC13P8 Y |
KEGG | D07764 Y |
ChEMBL | CHEMBL2106590 |
ECHA InfoCard | 100.036.025 |
Chemical and physical data | |
Formula | C13H25NO2 |
Molar mass | 227.34 |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Cyprodenate (Actebral) is a stimulant drug.[1] It was used for counteracting the effects of benzodiazepine tranquillizer drugs before the development of newer antidotes such as flumazenil.[2] It produces dimethylethanolamine as a metabolite, and so might be expected to produce nootropic effects.
See also
References
- ↑ Dormard Y, Levron JC, Le Fur JM. Pharmacokinetic study of maleate acid of 2-(N,N-dimethylaminoethanol-14C1)-cyclohexylpropionate (cyprodenate) and of N,N-dimethylaminoethanol-14C1 in animals. Arzneimittelforschung. 1975 Feb;25(2):201–7. PMID 1173033.
- ↑ Bobkov Yu.G., Morozov I.S.. Correction of psychodepressive effects of benzodiazepine tranquilizers by administration of psychoenergizers. Bulletin of Experimental Biology and Medicine. 1982 Oct;94(4):1366-1369. English. doi:10.1007/BF00827201.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.